Research Products

Economic Impacts of the Biotechnology, Medical Technology, and Pharmaceutical Industries’ Spending in New Jersey

Wednesday, May 11, 2011

Pharmaceutical/medical technology and biotechnology companies in New Jersey generate substantial economic impact through capital spending, research and development expenditures, and other operating expenditures. This spending generates direct and indirect economic impacts for New Jersey in the form of employment, income, gross domestic product, and state and local tax revenues. This report estimates these impacts based on data provided by BioNJ and the HealthCare Institute of New Jersey.

U.S. Labor Market & Industry
Workforce Policy & Practice
Product Type: 
Research Publications & Reports
File Type: 
Portable Document Format (.pdf)
PDF icon 2011_PHARMA_Economic_Impacts_NJ.pdf1.29 MB